Description
An NNRTI (Kis = 2.93 and 3.85-56.5 nM for wild-type and mutant HIV-1 RTs, respectively); inhibits wild-type and mutant HIV-1 viral replication in MT-4 human T lymphoid cells (IC95s = 1.5-1,500 nM); prevents RNA plus-strand initiation (IC50 = 17 nM); reduces HIV-1 cDNA in spleen of HIV-1-challenged HIV-susceptible transgenic rats,
Formal name: (4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
Synonyms: DMP 266|EFV|L-743,726
Molecular weight: 315.7
CAS: 154598-52-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)||Product Type|Biochemicals|Small Molecule Inhibitors|Reverse Transcriptases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS